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ABSTRACT
Previous studies have suggested that Mycobacte-
rium tuberculosis kasA G312S and G269S gene
mutations may represent sequence polymor-
phisms of the M. tuberculosis East-African-Indian
(EAI) and T families, respectively, rather than
relating to isoniazid resistance. The present study
examined polymorphisms of these two codons
in 98 drug-susceptible M. tuberculosis isolates
(68 EAI and 30 T isolates). Twenty-eight isolates
belonging to a sub-lineage of the EAI family had
the kasA G312S mutation, but none of the 30 T
isolates had the G269S mutation. The data suggest
that the kasA G312S mutation is not related to
isoniazid resistance, but represents a sequence
polymorphism in a sub-lineage of the EAI family.
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The Mycobacterium tuberculosis kasA gene encodes
a b-ketoacyl-ACP synthase, a potential target of
the first-line anti-tuberculosis agent isoniazid [1].
Nucleotide and amino-acid sequence changes at
codons 66 (GATﬁAAT), 269 (GGTﬁAGT), 312
(GGCﬁAGC) and 413 (TTCﬁTTA) of the kasA
gene have been postulated to be mutations asso-
ciated with isoniazid resistance because these
mutations were found originally in isoniazid-
resistant, but not in isoniazid-susceptible
M. tuberculosis isolates [1]. However, since this
hypothesis was suggested, the kasA G269S
(GGTﬁAGT) and G312S (GGCﬁAGC) mutations
have frequently been detected in both isoniazid-
resistant and isoniazid-susceptible isolates [2–8],
and therefore their role in isoniazid resistance is
uncertain.
In a previous study from Singapore, Lee et al.
[2] investigated the presence of kasA mutations in
160 isoniazid-resistant and 32 drug-susceptible
(including isoniazid, rifampicin, streptomycin
and ethambutol) clinical isolates of M. tuber-
culosis. The kasA G312S (GGCﬁAGC) mutation
occurred in 11 of 160 isoniazid-resistant isolates,
as well as in six of 32 drug-susceptible isolates,
while the kasA G269S (GGTﬁAGT) mutation
occurred only in three isoniazid-resistant isolates.
In a further molecular epidemiological study of
the same 160 isoniazid-resistant isolates [9], all 11
of the isoniazid-resistant isolates with the kasA
G312S mutation belonged to one evolutionary
clade of the M. tuberculosis East-African-Indian
(EAI) family, while all three of the isoniazid-
resistant isolates with the kasA G269S mutation
belonged to the M. tuberculosis T family and
shared a nearly identical 13-band IS6110 restric-
tion fragment length polymorphism (RFLP)
pattern (one isolate showed a single band trans-
position).
These data suggest that the kasA G312S and
G269S mutations are unlikely to be related
directly to isoniazid resistance, but may represent
sequence polymorphisms associated with sub-
lineages of the M. tuberculosis EAI and T families,
respectively. To test this hypothesis, the present
study examined kasA 312 and 269 polymor-
phisms in drug-susceptible M. tuberculosis isolates
belonging to the EAI and T families.
Isolates were selected from among 364 drug-
susceptible M. tuberculosis isolates that had been
collected at approximately the same time as the
isoniazid-resistant isolates and had been typed
using IS6110 RFLP analysis, spoligotyping and
mycobacterial interspersed repetitive unit vari-
able number tandem repeat analysis [9]. For the
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present study, 68 EAI isolates and 30 T isolates
were selected for kasA 312 and 269 polymorph-
ism analysis using DNA sequencing. The kasA
codon 312 and codon 269 flanking primers
5¢-GCTCATCGAGACGGAGGA (forward) and
5¢-CACCGTGAGCACCGACTC (reverse) were
used for PCR. Amplification and subsequent
DNA sequencing experiments were repeated
to confirm the results obtained. IS6110 RFLP
patterns and the unweighted pair-group method
using arithmetic averages (UPGMA) algorithm
were used to produce a dendogram showing
the relationships between the isolates.
Of the 68 EAI isolates, 28 had the kasA G312S
mutation, while the remaining isolates were wild-
type at kasA 312. As shown in Fig. S1 (see
Supplementary material), all kasA G312S mutant
isolates were clustered in a distinctive clade on
the dendrogram of IS6110 RFLP patterns, and this
clade branched into three sub-clades. These
isolates had between nine and 14 copies of
IS6110, but most had 10–13 copies, with c. 60%
of IS6110 RFLP similarity being shared. Spoligo-
typing patterns revealed that all the kasA G312S
mutant isolates failed to show hybridisation in
spacers 3, 20 and 21, as well as in spacers 29–32
and 34, which are absent from all EAI strains [10].
None of the 30 T isolates had the kasA G269S
mutation.
These data provide conclusive evidence that
the kasA G312S mutation in M. tuberculosis is not
related to isoniazid resistance, but is a sequence
polymorphism associated with an evolutionary
clade of the ancestral EAI family strains. The
spoligotyping patterns of the kasA G312S mutant
isolates showed that they have expanded clon-
ally. As the other EAI isolates and the isolates
belonging to other families had the wild-type
kasA 312, the kasA G312S mutants therefore
represent evolutionarily more recent EAI strains.
Based on spoligotyping patterns, the kasA G312S
mutants correspond to strains with shared
type 19, which has been designated as the
EAI2-Manila sub-lineage and accounts for 1.5%
of isolates in an international spoligotyping
database [11].
Three isoniazid-resistant T family isolates
with the kasA G269S mutation that were iden-
tified in an earlier study [9] were derived from
the same strain, indicating that they were a
transmission cluster. In the drug-susceptible
collection of T isolates, none showed an IS6110
RFLP pattern similar to that of the three kasA
G269S mutant isolates; however, the relatively
small number of susceptible isolates tested
could explain why the kasA G269S mutation
was not found among the drug-susceptible
T isolates examined. A recent study [12] of 608
isoniazid-susceptible and 403 isoniazid-resistant
isolates, collected mainly from areas in which
the T genotype is prevalent, detected the kasA
G269S mutation in 9% of isoniazid-resistant and
14% of isoniazid-susceptible isolates, suggesting
that this mutation is unlikely to have a causative
role in mycobacterial resistance to isoniazid. It
was also confirmed that the G312S mutation is
not involved in mycobacterial resistance to
isoniazid [12].
These findings have important implications
for the identification of drug-resistant mutations
in M. tuberculosis. Such mutations are usually
identified by comparing targeted gene
sequences of drug-resistant (case) and drug-
susceptible (control) isolates. If mutations are
observed in drug-resistant isolates but not in
drug-susceptible isolates, it is often assumed
that the mutations are related to drug resistance
[13]. However, findings obtained in such case-
control studies should be interpreted cautiously,
particularly concerning mutations that occur at
a low frequency. Sequence polymorphisms asso-
ciated with a specific evolutionary clade of a
given family, e.g., kasA G269S and G312S (this
study) and the rrs nucleotide 491 C to T
transition [14], may not be identified readily in
drug-susceptible isolates in geographical loca-
tions where specific clades of strains are not
prevalent. First, most case-control studies for
identifying drug-resistant genetic alterations
analyse fewer control isolates than case isolates
[2,6,13], and control isolates may not include
relevant clade isolates. Second, certain lineages
can be over-represented among case isolates
[4,9] compared to control isolates because there
are specific associations between M. tuberculosis
evolutionary lineages and drug-resistant muta-
tions [15,16]. It is therefore recommended that
genotyping of all isolates should be performed
so that both case and control isolates are
represented by the same distribution of geno-
types, thus allowing better discrimination of
true drug resistance mutations.
 2007 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 816–842
834 Clinical Microbiology and Infection, Volume 13 Number 8, August 2007
ACKNOWLEDGEMENTS
We acknowledge the Central Tuberculosis Laboratory,
Department of Pathology, Singapore General Hospital, for
providing isolates. Y.-J. Sun is a research scientist supported
by the National Medical Research Council (NMRC) of
Singapore.
SUPPLEMENTARY MATERIAL
The following supplementary material for this
article is available online at http://www.black
well-synergy.com:
Fig. S1. Dendogram and fingerprints of 68
Mycobacterium tuberculosis isolates belonging to
the East-African-Indian (EIA) family.
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